Director, Infrastructure Enblement

Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.

Ginkgo believes that if we are to grow a thriving, sustainable bioeconomy, we must also grow a new market in biosecurity. Our biosecurity and public health initiative, Concentric by Ginkgo, launched a nationwide emergency response to the COVID-19 pandemic, providing end-to-end pathogen monitoring services to schools, communities, and travelers. As we continue to scale Concentric, our work is also evolving into new and exciting directions, from global expansion to the integration of new technologies and capabilities, including our Traveler-Based Genomic Surveillance Plan with the CDC.

You will be the final decision maker on high level technical decisions and responsible for the overall architecture of our systems. You will work with the Software Team to ensure the architecture is implemented as intended and refine it as new knowledge arises from implementation.

In order to succeed in this role you need a track record of successful software delivery, be up to date with current technologies (especially AWS), be able to create proof of concepts and communicate technical concepts and decisions concisely and accurately. You will thrive if you are a self-starter motivated to bring organism engineering to new heights.

Responsibilities

• Define, maintain and communicate Concentric’s Software Architecture with input from the Software Team
• Collaborate with the Product Management and Software Teams to define and track roadmaps for implementation of the architecture
• Make Build vs Buy decisions
• Research third party software assets and identify candidates to add to the Concentric portfolio
• Create proof of concepts for major software components
• Collaborate with the Data team to ensure our Data Architecture will support analytics across the organization
• Champion and implement continuous process improvements to enhance productivity

Minimum Requirements

• Bachelor’s + minimum 15 years of experience OR Masters + minimum 10 years of experience
• 5 years of AWS experience
• Superb communication skills with all stakeholders
• Proficiency in agile development.
• Demonstrated ability to break down complex problems into actionable steps.
• Excited to work with the best scientists and engineers to develop new data tools to solve never-before-seen scientific challenges.
• Superior troubleshooting skills in large system

Preferred Capabilities and Experience

• Industry experience in biology, biological engineering, synthetic biology, or a related field.
• Strong attention to detail, with the ability to manage and prioritize multiple, concurrent responsibilities
• Flexibility to work in a fast-paced environment
• Eagerness to support Concentric’s goals, with a strong drive to help our initiative succeed

Total compensation for this role is market driven, with a starting salary of $170k+, as well as company stock awards. Base pay is ultimately determined based on a candidate's skills, expertise, and experience. We also offer a comprehensive benefits package including medical, dental & vision coverage, health spending accounts, voluntary benefits, leave of absence policies, Employee Assistance Program, 401(k) program with employer contribution, 8 paid holidays in addition to a full-week winter shutdown and unlimited Paid Time Off policy.

• What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
• Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
• Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
• Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
• Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
• Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
• The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
• Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
• Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
• Can This Company Convince You to Love GMOs? (The Atlantic)